Comcast, McKesson, Humana and Independence Health all scored exits as the health benefits services provider floated in an upscaled offering.

University of Zurich-founded skin graft therapy developer Cutiss increased its funding total to $29.3m with a round featuring Wyss Foundation.

Drug developer CF PharmTech has raised $50m in an SAIC-backed series F round just six months after closing $90m in series E funding.

McKesson Ventures came onboard for the health data provider Evidation's series D round, helping it hike its overall funding to $106m.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

The round pushed the overall funding for Stanford's autoimmune and neurodegenerative disorder drug developer past $250m.

The round pushed the overall funding for the Novartis-backed autoimmune and neurodegenerative disorder drug developer past $250m.

Aquitaine Science Transfert's new incubator will provide $22,600 of initial funding to help build out nascent deep tech projects.

Novo, Pfizer and Nan Fung helped provide $93.5m for the Stanford immunotherapy spinout as it advances its lead asset towards the clinic.

Novo, Pfizer and Nan Fung helped provide $93.5m for the cancer treatment developer as it advances its lead product candidate towards the clinic.